1. Role of Genomic Markers in Colorectal Cancer Treatment
    Wendy L. Allen et al, 2005, JCO CrossRef
  2. Thymidylate Synthase and Methylenetetrahydrofolate Reductase Gene Polymorphism in Normal Tissue As Predictors of Fluorouracil Sensitivity
    Anders Jakobsen et al, 2005, JCO CrossRef
  3. Uridine Diphosphate Glucuronosyltransferase (UGT) 1A1 and Irinotecan: Practical Pharmacogenomics Arrives in Cancer Therapy
    Peter J. O'Dwyer et al, 2006, JCO CrossRef
  4. Thymidylate Synthase 5’ UTR Polymorphic Allele Distribution in South Florida Population
    Hiba Hammad et al, 2012, JCT CrossRef
  5. Genetic Strategies to Individualize Supportive Care
    Howard L. McLeod, 2002, JCO CrossRef
  6. Tumor Thymidylate Synthase 1494del6 Genotype As a Prognostic Factor in Colorectal Cancer Patients Receiving Fluorouracil-Based Adjuvant Treatment
    Emma Dotor et al, 2006, JCO CrossRef
  7. Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years
    Mariusz Panczyk, 2014, WJG CrossRef
  8. Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids
    Amirsaeed Sabeti Aghabozorgi et al, 2020, WJGO CrossRef
  9. Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors
    Laura Grumetti et al, 2022, Cancers CrossRef
  10. Orotate Phosphoribosyltransferase Gene Polymorphism Predicts Toxicity in Patients Treated with Bolus 5-Fluorouracil Regimen
    Wataru Ichikawa et al, 2006 CrossRef
  11. Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
    Carla M.M. Prado et al, 2009 CrossRef
  12. Loss of Heterozygosity at the Thymidylate Synthase ( TS ) Locus on Chromosome 18 Affects Tumor Response and Survival in Individuals Heterozygous for a 28-bp Polymorphism in the TS Gene
    Kazumi Uchida et al, 2004 CrossRef
  13. Thymidylate Synthase Messenger RNA Expression in Plasma from Patients with Colon Cancer: Prognostic Potential
    Vanesa Garcia et al, 2006 CrossRef
  14. Germline Genetic Testing to Predict Drug Response and Toxicity in Oncology— Reality or Fiction?
    Thomas IP Soh et al, 2011, Ann Acad Med Singap CrossRef
  15. Resveratrol as sensitizer in colorectal cancer plasticity
    Aranka Brockmueller et al, 2023, Cancer Metastasis Rev CrossRef